ERBB2 and invasive carcinoma: Public dataset analyses have also confirmed that the decrease in SFRP1 expression among tumoral tissue compared to non-tumoral tissue could be mediated by its promoter, hypermethylation, in luminal and HER2 invasive carcinomas [40,42,46].